Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation

Renal interstitial fibrosis is a common pathological feature in progressive kidney diseases currently lacking effective treatment. Nicotinamide (NAM), a member of water‐soluble vitamin B family, was recently suggested to have a therapeutic potential for acute kidney injury (AKI) in mice and humans....

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Meiling, Cai, Juan, Liu, Zhiwen, Shu, Shaoqun, Wang, Ying, Tang, Chengyuan, Dong, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533567/
https://www.ncbi.nlm.nih.gov/pubmed/30993884
http://dx.doi.org/10.1111/jcmm.14285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533567/
https://www.ncbi.nlm.nih.gov/pubmed/30993884
http://dx.doi.org/10.1111/jcmm.14285

Ejemplares similares